Tilray Brands Launches Tilray Medical Italia to Expand Medical Cannabis Operations in Italy

Reuters01-22
Tilray Brands Launches Tilray Medical Italia to Expand Medical Cannabis Operations in Italy

Tilray Brands Inc. has expanded its presence in Italy with the launch of Tilray Medical Italia, rebranding its former entity FL Group. This move is part of Tilray’s strategy to strengthen its unified medical cannabis platform across Europe. The company is growing its portfolio of medical cannabis products authorized by the Italian Ministry of Health, supported by a partnership with Molteni Farmaceutici, a leading Italian pharmaceutical firm. Tilray Medical Italia now supplies pharmaceutical-grade medical cannabis to pharmacies throughout Italy, offering a range of medical cannabis flowers and oils available by prescription.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tilray Brands Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9629670-en) on January 22, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment